Published in Proc Natl Acad Sci U S A on April 28, 1998
MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem (2009) 3.34
Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J Card Fail (2009) 2.89
Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A (2000) 2.45
Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation (2001) 2.22
Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A (2001) 1.94
SUMO1-dependent modulation of SERCA2a in heart failure. Nature (2011) 1.89
Gene therapy in heart failure. Circ Res (2008) 1.79
Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression. J Clin Invest (2003) 1.78
Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation (2009) 1.71
Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J Clin Invest (2004) 1.58
Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J Mol Cell Cardiol (2007) 1.54
Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases. J Clin Invest (1999) 1.50
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway. Cardiovasc Res (2012) 1.48
Gene therapy for heart failure. Circ Res (2012) 1.46
Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure. Expert Opin Biol Ther (2010) 1.41
Determinants of frequency-dependent contraction and relaxation of mammalian myocardium. J Mol Cell Cardiol (2007) 1.29
Targeted high-efficiency, homogeneous myocardial gene transfer. J Mol Cell Cardiol (2007) 1.26
Gene therapy to treat cardiovascular disease. J Am Heart Assoc (2013) 1.13
Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. J Clin Invest (1999) 1.12
Targeting calcium cycling proteins in heart failure through gene transfer. J Physiol (2003) 1.12
Rescuing the failing heart by targeted gene transfer. J Am Coll Cardiol (2011) 1.11
JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure. Cell Death Dis (2012) 1.11
Effects of CXCR4 gene transfer on cardiac function after ischemia-reperfusion injury. Am J Pathol (2010) 1.10
Cardiac gene therapy with SERCA2a: from bench to bedside. J Mol Cell Cardiol (2010) 1.05
Intracellular devastation in heart failure. Heart Fail Rev (2008) 1.04
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. Am J Physiol Heart Circ Physiol (2005) 1.04
Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation. Circ Heart Fail (2010) 1.00
New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy. Trends Cardiovasc Med (2007) 0.98
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling. Gene Ther (2006) 0.97
Current strategies for myocardial gene delivery. J Mol Cell Cardiol (2010) 0.95
Spontaneous ventricular fibrillation in right ventricular failure secondary to chronic pulmonary hypertension. Circ Arrhythm Electrophysiol (2011) 0.95
The evolution of heart gene delivery vectors. J Gene Med (2011) 0.92
Cardiac gene therapy: optimization of gene delivery techniques in vivo. Hum Gene Ther (2010) 0.89
Potential role of BNIP3 in cardiac remodeling, myocardial stiffness, and endoplasmic reticulum: mitochondrial calcium homeostasis in diastolic and systolic heart failure. Circ Heart Fail (2013) 0.89
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure. Cardiovasc Res (2010) 0.88
Gene delivery technologies for cardiac applications. Gene Ther (2012) 0.87
Expression of neuronal nitric oxide synthase in rabbit carotid body glomus cells regulates large-conductance Ca2+-activated potassium currents. J Neurophysiol (2010) 0.87
Site-specific gene therapy for cardiovascular disease. Curr Opin Drug Discov Devel (2010) 0.87
Ectopic expression of KCNE3 accelerates cardiac repolarization and abbreviates the QT interval. J Clin Invest (2002) 0.87
SERCA2a: a prime target for modulation of cardiac contractility during heart failure. BMB Rep (2013) 0.85
SERCA2a gene therapy for heart failure: ready for primetime? Mol Ther (2008) 0.85
Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications. Hum Gene Ther (2013) 0.85
Concomitant intravenous nitroglycerin with intracoronary delivery of AAV1.SERCA2a enhances gene transfer in porcine hearts. Mol Ther (2012) 0.84
Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol (2011) 0.84
Cardiac gene therapy: from concept to reality. Curr Heart Fail Rep (2012) 0.84
Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol (2011) 0.84
Cardiac gene therapy. Semin Thorac Cardiovasc Surg (2010) 0.83
A designed zinc-finger transcriptional repressor of phospholamban improves function of the failing heart. Mol Ther (2012) 0.83
Gene therapy for ventricular tachyarrhythmias. Gene Ther (2012) 0.82
Lipidoid mRNA Nanoparticles for Myocardial Delivery in Rodents. Methods Mol Biol (2017) 0.82
Immunosuppression decreases inflammation and increases AAV6-hSERCA2a-mediated SERCA2a expression. Hum Gene Ther (2012) 0.82
Targeting sarcoplasmic reticulum calcium ATPase by gene therapy. Hum Gene Ther (2013) 0.81
Regenerative therapies in electrophysiology and pacing: introducing the next steps. J Interv Card Electrophysiol (2010) 0.78
Defining the success of cardiac gene therapy: how can nuclear imaging contribute? Eur J Nucl Med Mol Imaging (2003) 0.78
Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy. Biochim Biophys Acta (2015) 0.77
In vivo gene delivery of XIAP protects against myocardial apoptosis and infarction following ischemia/reperfusion in conscious rabbits. Life Sci (2011) 0.77
Cardiac gene therapy: are we there yet? Gene Ther (2016) 0.77
In vivo, cardiac-specific knockdown of a target protein, malic enzyme-1, in rat via adenoviral delivery of DNA for non-native miRNA. Curr Gene Ther (2012) 0.76
The Use of Gene Therapy for Ablation of Atrial Fibrillation. Arrhythm Electrophysiol Rev (2014) 0.75
Gene therapy for myocardial infarction-associated congestive heart failure: how far have we got? Dialog Cardiovasc Med (2009) 0.75
Mutual inhibition of insulin signaling and PHLPP-1 determines cardioprotective efficiency of Akt in aged heart. Aging (Albany NY) (2016) 0.75
Beta-Adrenergic gene therapy for cardiovascular disease. Curr Control Trials Cardiovasc Med (2000) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res (1994) 5.01
Rate of calcium binding and uptake in normal animal and failing human cardiac muscle. Membrane vesicles (relaxing system) and mitochondria. Circ Res (1969) 2.29
Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circ Res (1997) 2.12
Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes. Circulation (1997) 1.98
Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest (1997) 1.83
The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther (1994) 1.82
Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res (1994) 1.81
Phospholamban: a prominent regulator of myocardial contractility. Circ Res (1996) 1.78
Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci U S A (1993) 1.72
Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus. J Clin Invest (1993) 1.51
Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res (1993) 1.51
Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circ Res (1996) 1.48
Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation (1994) 1.45
Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther (1994) 1.43
Adenovirus-mediated gene transfer reconstitutes depressed sarcoplasmic reticulum Ca2+-ATPase levels and shortens prolonged cardiac myocyte Ca2+ transients. Circulation (1997) 1.28
Ultrarapid, highly efficient viral gene transfer to the heart. Proc Natl Acad Sci U S A (1997) 1.27
Intracellular calcium homeostasis in cardiac myocytes. Circulation (1993) 1.24
Targeted ablation of the phospholamban gene is associated with a marked decrease in sensitivity in aortic smooth muscle. Circ Res (1997) 1.08
Identification of a cis-acting sequence in the human plasminogen activator inhibitor type-1 gene that mediates transforming growth factor-beta1 responsiveness in endothelium in vivo. J Biol Chem (1996) 1.02
Differential sensitivity to isoprenaline of troponin I and phospholamban phosphorylation in isolated rat hearts. Biochem J (1990) 0.94
Sarcoplasmic reticulum calcium mobilization in right ventricular pressure-overload hypertrophy in the ferret: relationships to diastolic dysfunction and a negative treppe. Pflugers Arch (1993) 0.86
Myocardial Ca(2+)- and ATP-cycling imbalances in end-stage dilated and ischemic cardiomyopathies. Cardiovasc Res (1995) 0.85
Relationship of abnormal intracellular calcium mobilisation to myocyte hypertrophy in human ventricular myocardium. Cardiovasc Res (1993) 0.84
XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell (2001) 18.68
Multiple factors required for accurate initiation of transcription by purified RNA polymerase II. J Biol Chem (1980) 10.78
Multiple factors are required for the accurate transcription of purified genes by RNA polymerase III. J Biol Chem (1980) 10.63
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature (2001) 7.06
Apoptosis in myocytes in end-stage heart failure. N Engl J Med (1996) 6.19
The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest (1996) 5.29
The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med (1996) 5.06
Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell (1998) 4.73
Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med (1992) 4.20
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature (1999) 4.19
Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation (2001) 3.98
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res (1987) 3.86
Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell (1998) 3.69
Antitumor agents. 203. Carbazole alkaloid murrayaquinone A and related synthetic carbazolequinones as cytotoxic agents. J Nat Prod (2000) 3.62
Regulation of Escherichia coli starvation sigma factor (sigma s) by ClpXP protease. J Bacteriol (1996) 3.59
Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation (1999) 3.19
Identification of a putative target for Rho as the serine-threonine kinase protein kinase N. Science (1996) 3.09
A role for oestrogens in the male reproductive system. Nature (1997) 2.99
Genetic regulation of storaage protein content in maize endosperm. Biochem Genet (1976) 2.97
Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation (1995) 2.97
Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors. Science (1993) 2.94
Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science (1990) 2.86
Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol (1995) 2.84
Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity. J Nucl Cardiol (2001) 2.70
Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J (2000) 2.49
Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell (1999) 2.46
The protein family of RNA helicases. Crit Rev Biochem Mol Biol (1998) 2.46
Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A (2000) 2.45
Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents. J Med Chem (1996) 2.44
Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A (1999) 2.42
Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol (2000) 2.40
Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation (1999) 2.40
ACE inhibitors and pneumonia. Lancet (1998) 2.38
Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery. Anesthesiology (1992) 2.35
Akt participation in the Wnt signaling pathway through Dishevelled. J Biol Chem (2001) 2.31
The statistical mechanics of complex signaling networks: nerve growth factor signaling. Phys Biol (2004) 2.24
Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation (2001) 2.22
Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation (1990) 2.22
Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation (1997) 2.22
Assessment of reducibility of ileocolic intussusception in children: usefulness of color Doppler sonography. Radiology (1994) 2.20
A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study. Health Technol Assess (2010) 2.20
The magnitude of the backbone conformational entropy change in protein folding. Proteins (1996) 2.18
Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med (2003) 2.16
Immunofluorescence detection of ezrin/radixin/moesin (ERM) proteins with their carboxyl-terminal threonine phosphorylated in cultured cells and tissues. J Cell Sci (1999) 2.15
Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med (1993) 2.14
The molecular nature of zebrafish swirl: BMP2 function is essential during early dorsoventral patterning. Development (1997) 2.14
Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. J Nat Prod (1994) 2.12
Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circ Res (1997) 2.12
Central role for cdc45 in establishing an initiation complex of DNA replication in Xenopus egg extracts. Genes Cells (2000) 2.12
Abdominal amyloidosis: spectrum of radiological findings. Clin Radiol (2003) 2.10
Features of myocardial injury in severe organophosphate poisoning. Clin Toxicol (Phila) (2014) 2.09
Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res (2004) 2.09
Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J (1999) 2.08
Laparoscopy in the surgical treatment of rectal cancer in Germany 2000-2009. Colorectal Dis (2012) 2.07
Changes in epidural pressure during walking in patients with lumbar spinal stenosis. Spine (Phila Pa 1976) (1995) 2.06
Factors affecting nuclear export of the 60S ribosomal subunit in vivo. Mol Biol Cell (2000) 2.00
Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol (1992) 2.00
Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med (1985) 1.99
Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes. Circulation (1997) 1.98
Dna2 of Saccharomyces cerevisiae possesses a single-stranded DNA-specific endonuclease activity that is able to act on double-stranded DNA in the presence of ATP. J Biol Chem (1998) 1.97
Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol (1992) 1.96
Idiopathic calcinosis of the scrotum: histopathologic observations of fifty-one nodules. J Am Acad Dermatol (1988) 1.93
Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circulation (2000) 1.93
An efficient directional cloning system to construct cDNA libraries containing full-length inserts at high frequency. Gene (1989) 1.90
Studies on the mechanism of action of salicylate. II. Retardation of wound healing by aspirin. J Pharm Sci (1968) 1.90
Morbidity and mortality associated with pancreatogastrostomy and pancreatojejunostomy following partial pancreatoduodenectomy. Br J Surg (2002) 1.89
Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol (2001) 1.87
Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res (2001) 1.87
Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation (1991) 1.85
Noninvasive estimation of the instantaneous first derivative of left ventricular pressure using continuous-wave Doppler echocardiography. Circulation (1991) 1.84
Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus. Antimicrob Agents Chemother (1987) 1.82
Socioeconomic status as an independent risk factor for hospital readmission for heart failure. Am J Cardiol (2001) 1.81
Expression of a kinase-defective Eph-like receptor in the normal human brain. Biochem Biophys Res Commun (1997) 1.79
Activation of phospholipase C isozymes by G protein beta gamma subunits. J Biol Chem (1993) 1.78